BBT-032

N/A

Report date: 2024/12/18 13:39:48

Base Information

Drug NameBBT-032
Drug Alias NameBBT-032
ClassificationBiologics > Protein drugs > Recombinant protein
Mechanisms of ActionInterferon alpha/beta receptor agonists
TargetsInterferon alpha/beta receptor
Therapy Area/IndicationsCoronavirus Disease 2019 (COVID-19)Multiple Sclerosis
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryN/A
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesBolder Biotechnology
China Registration ClassN/A

Develop Information

Active CompaniesBolder Biotechnology
Inactive CompaniesN/A
Active IndicationsCoronavirus Disease 2019 (COVID-19)Multiple Sclerosis
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A